SEC 13F Intelligence

Sg Americas Securities, LLC / VRTX

Sg Americas Securities, LLC’s Vertex Pharmaceuticals Inc Position

Does Sg Americas Securities, LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 57.0K shares worth $25M (+0.03% of its 13F portfolio) as of Q1 2026, down from 115.9K shares the prior filed quarter.

Position Value
$25M
Q1 2026
Shares
57.0K
% of Portfolio
+0.03%
Quarters Held
30
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $321,000Q4 ’18Q1 ’19: $3MQ2 ’19: $6MQ3 ’19: $15MQ4 ’19: $5MQ4 ’19Q1 ’20: $5MQ2 ’20: $13MQ3 ’20: $8MQ4 ’20: $11MQ4 ’20Q1 ’21: $7MQ2 ’21: $25MQ3 ’21: $1MQ4 ’21: $8MQ4 ’21Q1 ’22: $20MQ2 ’22: $11MQ3 ’22: $4MQ4 ’22: $5MQ4 ’22Q1 ’23: $5MQ2 ’23: $11MQ3 ’23: $5MQ4 ’23: $11MQ4 ’23Q1 ’24: $13MQ2 ’24: $37MQ3 ’24: $16MQ4 ’24: $2MQ4 ’24Q1 ’25: $11MQ2 ’25: $51MQ3 ’25: $24MQ4 ’25: $53MQ4 ’25Q1 ’26: $25Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202657.0K$25M+0.03%
Q4 2025115.9K$53M+0.07%
Q3 202560.1K$24M+0.08%
Q2 2025115.6K$51M+0.21%
Q1 202522.3K$11M+0.04%
Q4 20244.8K$2M+0.01%
Q3 202435.3K$16M+0.06%
Q2 202478.5K$37M+0.21%
Q1 202430.0K$13M+0.06%
Q4 202328.1K$11M+0.11%
Q3 202313.7K$5M+0.05%
Q2 202330.1K$11M+0.08%
Q1 202316.6K$5M+0.06%
Q4 202218.4K$5M+0.06%
Q3 202214.3K$4M+0.05%
Q2 202239.6K$11M+0.12%
Q1 202275.3K$20M+0.14%
Q4 202134.2K$8M+0.04%
Q3 20218.3K$1M+0.01%
Q2 2021123.3K$25M+0.12%
Q1 202131.3K$7M+0.04%
Q4 202045.3K$11M+0.06%
Q3 202029.1K$8M+0.05%
Q2 202044.7K$13M+0.11%
Q1 202021.8K$5M+0.05%
Q4 201920.9K$5M+0.04%
Q3 201989.1K$15M+0.12%
Q2 201934.0K$6M+0.04%
Q1 201916.3K$3M+0.03%
Q4 20181.9K$321,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sg Americas Securities, LLC’s full portfolio or all institutional holders of VRTX.